Federal award
PATHOSEQ BIO, LLC
N4034522P0126
Contract
Obligated and Ceiling
- Obligated (net)
- $248,637.36
- Ceiling (potential value, not spending)
- $248,637.36
- Current value
- $248,637.36
- Gross positive obligations
- $248,637.36
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- PATHOSEQ BIO, LLC · XZBGAKEK7K55
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- PATHOSEQ BIO, LLC · XZBGAKEK7K55
- Awarding agency
- Department of War · sub-agency 1700 · office N40345
- Funding agency
- Department of War · sub-agency 1700
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- N4034522P0126
- Award type code
- B
- Actions
- 3 · Sep 26, 2022 to Feb 22, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 22, 2023 | FY2023 | P00002 | M | $0.00 | — |
| Jan 10, 2023 | FY2023 | P00001 | M | $0.00 | — |
| Sep 26, 2022 | FY2022 | 0 | — | $248,637.36 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.